Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

2
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
2
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

4
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
4
Dementia l: Introduction01:22

Dementia l: Introduction

3
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
3
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing psychometric properties of the revised Richards-Campbell Sleep Questionnaire based on COSMIN: a systematic review.

Frontiers in medicine·2026
Same author

Revealing the chemical differences and their application on geographical origin and aging year identification of Artemisia Argyi Folium based on GC-MS and UHPLC-HRMS untargeted metabolomics.

Food research international (Ottawa, Ont.)·2026
Same author

Effects of drying methods on phenolic acids, flavonoids, and essential oils in three cultivars of <i>Artemisia Argyi</i>.

Food chemistry: X·2025
Same author

Probing Dopant Size Effects on Defect Clustering and Vacancy Ordering in Lanthanide-doped Ceria.

Journal of the American Chemical Society·2025
Same author

Preparation and mechanism of Lactobacillus plantarum and curcumin co-encapsulated in alginate-gelatin hydrogel beads.

Food chemistry·2025
Same author

Comparison of unplanned treatment interruption during CRRT in ICU patients under CVVH (pre + post dilution) or CVVHDF (post-dilution) mode: A retrospective cohort study.

Nursing in critical care·2025

Related Experiment Video

Updated: Apr 20, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

34.3K

Integrated cortical structural marker for Alzheimer's disease.

Jing Ming1, Michael P Harms2, John C Morris3

  • 1Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, USA.

Neurobiology of Aging
|December 3, 2014
PubMed
Summary

This study integrates brain surface measures to better identify early Alzheimer's disease (AD). Combining cortical thickness, white matter convexity, and surface distortion significantly improved diagnostic accuracy in individuals with very mild AD.

Keywords:
ClassificationConvexityCortical geometryCortical thicknessMetric distortionNeuroimaging

More Related Videos

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.6K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.1K

Related Experiment Videos

Last Updated: Apr 20, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

34.3K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.6K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.1K

Area of Science:

  • Neuroimaging
  • Neurology
  • Biomedical Engineering

Background:

  • Early diagnosis of Alzheimer's disease (AD) is crucial for effective management.
  • Distinguishing very mild AD from normal cognition using neuroimaging is challenging.

Purpose of the Study:

  • To develop and validate an approach integrating multiple cortical morphology measures for improved discrimination of very mild AD.
  • To assess the combined diagnostic power of gray matter thickness and white matter geometric measures.

Main Methods:

  • Applied FreeSurfer to MRI scans from 83 individuals with very mild AD and 124 controls.
  • Generated measures of cortex thickness, white matter convexity (sulcal depth), and surface metric distortion.
  • Utilized Principal Component Analysis (PCA), stepwise logistic regression, and 10-fold cross-validation for analysis.

Main Results:

  • Cortical thickness, convexity, and metric distortion showed complementary patterns reflecting gray and white matter changes.
  • The integrated classifier significantly outperformed classifiers based on single measures.
  • Generated global and surface-based AD likelihood maps.

Conclusions:

  • Integrating diverse cortical morphology measures enhances the ability to detect very mild Alzheimer's disease.
  • PCA-based integration offers a powerful framework for high-dimensional data analysis in early disease diagnosis.
  • This approach holds promise for future early diagnosis of neurodegenerative diseases with abnormal brain surface patterns.